

Resof-L Tablet (Sofosbuvir and Ledipasvir)
Manufactured By
Dr.reddy
Pack Of
28
Salt Composition
Sofosbuvir and Ledipasvir
Storage
Keep in cold place
ALL SUBSTITUTES
Overview
Resof-L Tablet is an antiviral medicine that is a combination of two antiviral medicines such as Ledipasvir (90mg) and Sofosbuvir (400mg). It is prescribes to treat chronic hepatitis C virus (HCV) infection. It works by reducing the viral load in the body and eliminating viruses from the blood over time. It should be taken in dose and duration as advice by the doctor. Don't take more than the recommended dose.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | resof-l |
| Generic / Active Ingredient | Sofosbuvir and Ledipasvir |
| Strength | 90 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | dr.reddy |
| Pack Size | 28 |
| Prescription Required | Yes |
| Therapeutic Categories | Hepatitis Medicines |
| Uses | hepatitis |
Uses and Indications
Hepatitis C
Side Effects of Resof-L Tablet
Resof-L Tablet(Ledipasvir (90mg) and Sofosbuvir (400mg)) is a strong antiviral medicine that may show certain adverse while manageable impact on the body during the treatment. As these effects resolve on their own without any special medical attention. However, if you ever experience serious or unusual side effects contact your healthcare professional immediately.
Some common side effects of Resof-L include:
● Nausea
● Vomiting
● Diarrhea
● Stomach pain
● Difficulty in falling asleep
● Irritability
● Chest pain
● Decreased appetite
● Muscle pain and cramps
Resof-L Tablet Dosage and How To Take It
Doctor determines the dosage and duration of Resof-L Tablet(Ledipasvir (90mg) and Sofosbuvir (400mg)) as per the severity of the infection as well as age & overall health condition of the patients. Swallow it as a whole with water and don't chew, crush or break the tablet. This tablet may be taken with or without food. In case of an overdose of this tablet, contact your doctor or any healthcare provider and seek medical attention immediately.
Safety Advice for Resof-L Tablet
- ● Alcohol: Avoid the consumption of alcohol while taking Resof-L Tablet, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms
- ● Pregnancy: Resof-L Tablet(Ledipasvir (90mg) and Sofosbuvir (400mg)) is safe to use during pregnancy, if prescribed by the doctor. No dosage adjustment is necessary for this tablet as limited data is available that shows significant risk.
- ● Breastfeeding: Resof-L Tablet is safe to use while breastfeeding, if prescribed by the doctor. No dosage adjustment is necessary for this tablet as limited data is available that shows significant risk.
- ● Driving: Resof-L Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
- ● Kidney: Share your medical history with the doctor before starting the Resof-L Tablet(Ledipasvir (90mg) and Sofosbuvir (400mg)). Do not take it without consulting a doctor if you have any kidney related issue.
- ● Liver: Resof-L Tablet is safe for use in liver disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
FAQs About Resof-L Tablet
Is it safe to take the Resof-L Tablet during pregnancy or breastfeeding?
Consumption of Resof-L(Ledipasvir (90mg) and Sofosbuvir (400mg)) during pregnancy & breastfeeding is considered to be safe. However, it is necessary to consult with a doctor in both cases.
Can I drive after taking Resof-L Tablet?
It is unsafe to drive after taking treatment with this medicine as lack of concentration or dizziness is the common side effect of Resof-L Tablet.
Is it safe to take other medicine with Resof-L Tablet?
As Resof-L can interact with some medicine. It is advisable to inform your doctor about any medicine you are taking.
What types of diseases are treatable with Resof-L Tablet(Ledipasvir (90mg) and Sofosbuvir (400mg))?
Resof-L prescribed to the patients with chronic hepatitis C virus (HCV) infection.
What are the common side effects of Resof-L Tablet?
There are some common yet manageable side effects of taking Resof-L that include diarrhea, headache, nausea, vomiting, anemia, etc.
References
● Mastanamma, S. K., Chandini, S. K., Reehana, S. K., & Saidulu, P. (2018). Development and validation of stability indicating RP-HPLC method for the simultaneous estimation of Sofosbuvir and Ledipasvir in bulk and their combined dosage form. Future journal of pharmaceutical sciences, 4(2), 116-123.
● Gane, E. J., Hyland, R. H., An, D., Svarovskaia, E., Pang, P. S., Brainard, D., & Stedman, C. A. (2015). Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection. Gastroenterology, 149(6), 1454-1461.
● Naggie, S., Cooper, C., Saag, M., Workowski, K., Ruane, P., Towner, W. J., ... & Sulkowski, M. (2015). Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1. New England Journal of Medicine, 373(8), 705-713.
● Lawitz, E., Poordad, F. F., Pang, P. S., Hyland, R. H., Ding, X., Mo, H., ... & Membreno, F. E. (2014). Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial. The Lancet, 383(9916), 515-523.
● Keating, G. M. (2015). Ledipasvir/Sofosbuvir: a review of its use in chronic hepatitis C. Drugs, 75(6), 675-685.
Marketer Details
Dr.reddy
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.



